Two of the three major U.S. stock indexes just wrapped up their worst quarter in well over two years. The third barely avoided the same fate. The S&P 500 dropped more than 4.5% for the first quarter ...

March 26 (Reuters) - Gene therapy maker bluebird bio (BLUE.O), opens new tab said on Tuesday it plans to revise its financial statements for 2022 and the first three quarters of last year due to ...

Revenue for the fourth quarter 2022 was $2.1 million compared to $1.1 million for the fourth quarter 2021. Revenue for the full year 2022 was $7.0 million, compared to $1.7 million for the full year ...